Bolton (MA), San Antonio (TX) September 7, 2016
Intrinsic Imaging, an FDA audited, ISO 9001, ISO 13485 and ISO 22301 certified imaging core lab, announced today that it has appointed Mr. Bryan Wayne, BSc., as Vice President of Imaging Operations.
Mr. Wayne specializes in providing imaging core lab services in support of Phase I-IV Clinical Trials and Class I, II and III Medical Device Trials. Mr. Wayne has over 11 years of experience in providing medical imaging core lab services and he has a proven record of managing international clinical trials across all therapeutic areas and indications.
Prior to joining Intrinsic Imaging, Mr. Wayne was a senior manager within PAREXEL, one of the world’s largest contract research organizations. At PAREXEL, Mr. Wayne managed large, complex clinical trials within their medical imaging division.
“Intrinsic Imaging is recognized worldwide for providing exceptional quality”, said Todd A. Joron, BSc., MBA, President and COO of Intrinsic Imaging. “As we continue our international growth, Mr. Wayne’s depth of experience and expertise will ensure operational excellence always remains synonymous with Intrinsic Imaging.”
Mr. Wayne holds a Bachelor of Science degree from the University of New Hampshire.
About Intrinsic Imaging
Located in Bolton, Massachusetts and San Antonio, Texas, Intrinsic Imaging is an FDA audited, ISO 9001:2008 and ISO 13485:2003 certified, GAMP® 5 compliant medical imaging core lab specializing in providing imaging core lab services for clinical trials. Its comprehensive medical imaging core lab services include, but are not limited to, expert radiologist consultation, protocol and charter development, site qualification, training and management, as well as image acquisition, processing and detailed radiologic analysis.
Intrinsic Imaging has more than sixty full-time, board-certified diagnostic radiologists on staff that have sub-specialization in all therapeutic areas including, but not limited to, Cardiovascular, Central Nervous System, Gastrointestinal & Genitourinary, Medical Device, Musculoskeletal and Oncology.